Novo Nordisk CEO says experimental weight loss pill could become a best-in-class drug
Lars Fruergaard Jørgensen's remarks came one day after Novo Nordisk impressed investors with early-stage trial data on amycretin.
Source link
- Environmental worries after ship hit in Red Sea sinks
- Despite distancing itself from politics, the topic is dominating Threads’ trends | TechCrunch
